AI assistant
VERACYTE, INC. — Director's Dealing 2020
Nov 6, 2020
31551_dirs_2020-11-06_e35fb509-d5b7-4f41-9e2c-cf7f91036f38.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2020-11-05
Reporting Person: Hanna John Walter JR (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-05 | Common Stock | M | 3125 | $9.05 | Acquired | 77434 | Direct |
| 2020-11-05 | Common Stock | M | 3281 | $5.98 | Acquired | 80715 | Direct |
| 2020-11-05 | Common Stock | S | 3613 | $39.9962 | Disposed | 77102 | Direct |
| 2020-11-05 | Common Stock | S | 2660 | $41.5594 | Disposed | 74442 | Direct |
| 2020-11-05 | Common Stock | S | 133 | $42.0801 | Disposed | 74309 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-05 | Stock Option (right to buy) | $9.05 | M | 3125 | Disposed | 2027-03-02 | Common Stock (3125) | Direct |
| 2020-11-05 | Stock Option (right to buy) | $5.98 | M | 3281 | Disposed | 2028-03-01 | Common Stock (3281) | Direct |
Footnotes
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.
F2: Represents weighted average sales price. Sale prices for the transactions range from $39.95 to $40.78. Detailed information regarding the number of shares sold at each separate price will be provided to the
SEC, the issuer or a shareholder upon request.
F3: Represents weighted average sales price. Sale prices for the transactions range from $41.01 to $42.01. Detailed information regarding the number of shares sold at each separate price will be provided to the
SEC, the issuer or a shareholder upon request.
F4: Represents weighted average sales price. Sale prices for the transactions range from $42.05 to $42.13. Detailed information regarding the number of shares sold at each separate price will be provided to the
SEC, the issuer or a shareholder upon request.
F5: The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
F6: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.